loading
前日終値:
$247.56
開ける:
$246
24時間の取引高:
321.87K
Relative Volume:
0.39
時価総額:
$16.02B
収益:
$4.44B
当期純損益:
$29.49M
株価収益率:
-13,413.59
EPS:
-0.0184
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
+0.93%
1か月 パフォーマンス:
-5.66%
6か月 パフォーマンス:
+30.80%
1年 パフォーマンス:
+92.79%
1日の値動き範囲:
Value
$244.75
$249.00
1週間の範囲:
Value
$241.02
$252.72
52週間の値動き範囲:
Value
$123.88
$266.38

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1074)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,890
Name
Twitter
@jazzpharma
Name
次回の収益日
2026-08-03
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
JAZZ icon
JAZZ
Jazz Pharmaceuticals Plc
246.81 16.14B 4.44B 29.49M 1.19B -0.0184
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
546.12 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
827.72 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,033.15 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
145.55 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
210.02 45.38B 742.00K -1.37B -1.07B -7.0731

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 再開されました Raymond James Outperform
2026-02-27 開始されました Barclays Overweight
2025-11-24 ダウングレード UBS Buy → Neutral
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
Aug 21, 2026

Advisors Preferred LLC Acquires New Shares in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Aug 21, 2026
pulisher
Aug 20, 2026

Jazz Pharmaceuticals (JAZZ) As HER2 Pipeline Progress Fuels An Undervalued Narrative - simplywall.st

Aug 20, 2026
pulisher
Aug 20, 2026

Great Lakes Advisors LLC Invests $8.15 Million in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Aug 20, 2026
pulisher
Aug 19, 2026

Jazz Pharmaceuticals Announces $820 Million Acquisition of Actio Biosciences - Global Legal Chronicle

Aug 19, 2026
pulisher
Aug 19, 2026

ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView

Aug 19, 2026
pulisher
Aug 18, 2026

Jessica Merrill: Mid-Cap Biopharma's $1B-Plus Deal Surge Could Spawn the Next Amgen - finance.biggo.com

Aug 18, 2026
pulisher
Aug 17, 2026

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Glimpse Into The 14.86% Potential Upside - DirectorsTalk Interviews

Aug 17, 2026
pulisher
Aug 15, 2026

Jazz Pharmaceuticals PLC at TD Cowen Oncology Innovation Summit (Virtual) Transcript - GuruFocus

Aug 15, 2026
pulisher
Aug 14, 2026

Understanding HER2 Expression in Gastroesophageal AdenocarcinomaJazz Pharmaceuticals - Oncodaily

Aug 14, 2026
pulisher
Aug 14, 2026

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

Jazz Pharmaceuticals plc: Target Price Consensus and Analysts Recommendations | JAZZ | IE00B4Q5ZN47 - marketscreener.com

Aug 14, 2026
pulisher
Aug 13, 2026

Irish Jazz Pharmaceuticals acquires American Actio for $1.32 billion - AKM.RU

Aug 13, 2026
pulisher
Aug 13, 2026

Jazz Pharmaceuticals (JAZZ) Stock Looks Cheap On Earnings While Broader Checks Stay Mixed - simplywall.st

Aug 13, 2026
pulisher
Aug 12, 2026

Jazz Pharmaceuticals Bolsters Epilepsy Division With Actio Biosciences Buyout (JAZZ) - Seeking Alpha

Aug 12, 2026
pulisher
Aug 12, 2026

Wedge Capital Management L L P NC Sells 33,467 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

5 Revealing Analyst Questions From Jazz Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance

Aug 11, 2026
pulisher
Aug 11, 2026

JAZZ Maintained by Morgan Stanley -- Price Target Raised to $283 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Jazz Pharmaceuticals (JAZZ) Acquires Actio Biosciences for $820 Million - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Jazz Pharmaceuticals' Actio Acquisition 'Makes Sense,' Has Good Synergy, RBC Says - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

Morgan Stanley Adjusts Jazz Pharmaceuticals PT to $283 From $280, Maintains Overweight Rating - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

Jazz Pharmaceuticals buys Actio for up to $1.3bn - BioXconomy

Aug 11, 2026
pulisher
Aug 11, 2026

Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront - Yahoo Finance

Aug 11, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals plc (JAZZ) stock price, news, quote and history - Yahoo Finance Singapore

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger - TipRanks

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals (JAZZ) plans $820M Actio Biosciences deal plus $500M milestones - Stock Titan

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals to acquire Actio Biosciences for $820M - Investing.com India

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Solid Earnings Are Supported By Other Strong Factors - 富途牛牛

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharma Buying Actio In Up To $1.32B Epilepsy Push - Law360

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz to buy rare epilepsy drugmaker in potentially $1.3B deal - BioPharma Dive

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - reuters.com

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline - BioSpace

Aug 10, 2026
pulisher
Aug 10, 2026

JAZZ Looks 70.7% Overvalued on GF Value™ Amid $820M Actio Biosci - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Unlocking Jazz (JAZZ) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals to Acquire Actio Biosciences in Deal Worth Up to $1.32 Billion - citybiz

Aug 10, 2026
pulisher
Aug 10, 2026

JAZZ Looks 68.7% Overvalued on GF Value™ After Actio Biosciences Acquisition - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals to Acquire Rare Epilepsy Specialist Actio - TipRanks

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals to acquire Actio Biosciences for $820M By Investing.com - Investing.com Australia

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront, gaining a new epilepsy drug ABS-1230. - Pluang

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio - PR Newswire

Aug 10, 2026
pulisher
Aug 10, 2026

Royal Bank of Canada Has $8.56 Million Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Jazz Pharmaceuticals (JAZZ): Investor Outlook on a Biotech Powerhouse with a 9.51% Upside Potential - DirectorsTalk Interviews

Aug 10, 2026
pulisher
Aug 09, 2026

Jazz Pharmaceuticals PLC (JAZZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 09, 2026
pulisher
Aug 07, 2026

Jazz Pharmaceuticals plc 2026 Q2ResultsEarnings Call Presentation (NASDAQ:JAZZ) 2026-08-07 - Seeking Alpha

Aug 07, 2026
pulisher
Aug 07, 2026

Jazz Pharmaceuticals plc SEC Filing (Aug 7, 2026) - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

Jazz Pharmaceuticals plc (JAZZ) News, Articles, Events & Latest Updates - Stocktwits

Aug 07, 2026
pulisher
Aug 06, 2026

JAZZ vs. TECH: Which Stock Is the Better Value Option? - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

FMR LLC and Abigail Johnson disclose 7.4% Jazz Pharmaceuticals (JAZZ) ownership - Stock Titan

Aug 06, 2026
pulisher
Aug 06, 2026

Jazz Pharmaceuticals (JAZZ) Director Bruce Cozadd Sells 6,000 Sh - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

Jazz Pharmaceuticals Plc Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next - Moomoo

Aug 06, 2026
pulisher
Aug 06, 2026

What Does Jazz Pharmaceuticals (JAZZ) Raised Guidance Mean With FDA Decisions Ahead? - Yahoo Finance

Aug 06, 2026

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$103.76
price up icon 0.86%
$126.29
price down icon 0.31%
$63.96
price up icon 0.13%
$266.11
price up icon 0.61%
ONC ONC
$358.26
price down icon 1.22%
$210.02
price down icon 0.40%
大文字化:     |  ボリューム (24 時間):